Testing for B-type natriuretic peptide in the diagnosis and assessment of heart failure: What are the nuances?

James B. Young, MD
Roundtable Moderator and Supplement Editor; Chairman, Division of Medicine; Head, Section of Heart Failure, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Natalie G. Correia, DO
Associate Director, Internal Medicine Residency; Staff, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Gary S. Francis, MD
Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Staff, Department of  Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Alan Maisel, MD
Professor of Medicine, University of California, San Diego, School of Medicine; Director, Coronary Care Unit, La Jolla VA Medical Center, San Diego, California

Franklin Michota, MD
Head, Section of Hospital Medicine, Department of General Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Dr.  Young reported that he has received grant/research support from Biosite Inc.

Dr. Correia reported that she has no relationships that could be perceived as a potential conflict of interest in the context of this supplement.

Dr. Francis reported that he serves on an advisory board to Biosite Inc.

Dr. Maisel reported that he has received grant/research support from, serves as a consultant to, and is on the speakers’ bureau of Biosite Inc. He also reported that he is on the speakers’ bureau of Scios Inc.

Dr. Michota reported that he serves as a consultant to Scios Inc.